Aprea Therapeutics Inc (APRE)
5.17
-0.20
(-3.72%)
USD |
NASDAQ |
Apr 24, 16:00
Aprea Therapeutics Total Liabilities (Quarterly): 5.697M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.697M |
| September 30, 2023 | 5.477M |
| June 30, 2023 | 5.262M |
| March 31, 2023 | 5.538M |
| December 31, 2022 | 4.512M |
| September 30, 2022 | 6.997M |
| June 30, 2022 | 76.46M |
| March 31, 2022 | 6.748M |
| December 31, 2021 | 7.316M |
| September 30, 2021 | 9.070M |
| Date | Value |
|---|---|
| June 30, 2021 | 10.60M |
| March 31, 2021 | 11.25M |
| December 31, 2020 | 15.41M |
| September 30, 2020 | 13.81M |
| June 30, 2020 | 14.70M |
| March 31, 2020 | 11.77M |
| December 31, 2019 | 9.364M |
| September 30, 2019 | 128.13M |
| June 30, 2019 | 5.878M |
| December 31, 2018 | 117.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.512M
Minimum
Dec 2022
128.13M
Maximum
Sep 2019
18.63M
Average
9.070M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 9.485M |
| Stoke Therapeutics Inc | 68.78M |
| Processa Pharmaceuticals Inc | 0.7975M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.65M |
| Shareholders Equity (Quarterly) | 16.95M |